BioMidwest
Filter News
Found 71,583 articles
-
BioSpace Hotbed maps have been a life sciences industry staple for over 30 years. Today the program features eight regional Hotbed Maps and the NextGen Bio Map which highlights some of the industry’s most promising startups.
-
Cancer Diagnostics, Inc. Acquires Anatech, Ltd.
6/18/2021
Cancer Diagnostics, Inc. (CDI), a Durham, North Carolina-based industry-leading provider of anatomic pathology products, has acquired Anatech Ltd.,
-
Avanos Medical, Inc. to Present at the 2021 Raymond James Human Health Innovation Conference
6/18/2021
Avanos Medical, Inc. announced that Joe Woody, chief executive officer, will present and participate in an analyst-led fireside chat at the Virtual 2021 Raymond James Human Health Innovation Conference Tues., June 22 at approximately 10:40 a.m., ET.
-
Predictive Oncology Announces Closing of $21.34 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
6/18/2021
Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that it has completed the closing of its previously announced registered direct offering of 15,520,911 shares of its common stock and warrants
-
Global science and technology innovator Danaher Corporation is adding another company to its ever-growing global operation.
-
New research shows T cells can be engineered to migrate more effectively inside tumor microenvironments, raising hopes of reproducing the remarkable outcomes seen for certain hematological cancer patient subsets in broader populations and indications.
-
Avisa Diagnostics to Participate in Renmark’s Virtual Non-Deal Roadshow Series on June 17, 2021
6/17/2021
Avisa Diagnostics Inc. announced that the Company will participate in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series on June 17, 2021 at 12:00 PM ET.
-
Lilly Launches Think Talk Treat Migraine™ to Help Improve Diagnosis and Treatment of Migraine
6/17/2021
Eli Lilly and Company (NYSE: LLY) launched Think Talk Treat Migraine™, a new initiative to empower people living with migraine and their primary care providers to recognize key symptoms of migraine and have better conversations about the disease that can lead to proper diagnosis and treatment.
-
OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland
6/17/2021
OPKO Health, Inc. announces that its subsidiary, EirGen Pharma, Ltd., has entered into a definitive agreement to sell one of its facilities in Waterford, Ireland to Horizon Therapeutics plc for $65 million in cash less certain assumed and accrued liabilities relating to transferred employees.
-
AOAC Approves NEOGEN Soleris® Direct Yeast and Mold for Use in Cannabis
6/17/2021
NEOGEN Corporation's (NASDAQ: NEOG) Soleris® Direct Yeast and Mold test has received the Performance Tested MethodsSM Certification from the AOAC Research Institute's Emergency Response Validation Process for the enumeration of yeasts and molds in dried cannabis flower [9-tetrahydrocannabinol (THC) >0.3%].
-
Creative Medical Technology Holdings To Present ImmCelz® Subsidiary At World Stem Cell Conference
6/17/2021
Creative Medical Technology Holdings, Inc., announced that the company will virtually present at the Investor Forum at the World Stem Cell Summit Thursday, June 17, 2021 at 12:00pm Eastern Standard Time and will consist of a 20-minute formal description of the Company followed by a 20-minute Q&A session moderated by a Noble Capital Markets equity research representative.
-
Clean Republic Announces SARS-CoV-2 (Covid-19 Virus) 60-Second Kill Claim
6/17/2021
Clean Republic, a market leader in cleaning, sanitization and disinfection innovations, has received EPA approval to amend the label of its OMRI-Certified disinfectant to reflect its proven 60-second kill claim against SARS-CoV-2, the virus that causes Covid-19, on hard, non-porous surfaces.
-
AbbVie Declares Quarterly Dividend - June 17, 2021
6/17/2021
The board of directors of AbbVie Inc. declared a quarterly cash dividend of $1.30 per share.
-
Blue Water Vaccines Announces the Appointments of Former Congressman Theodore S. Yoho as the Head of Business Development and Manufacturing Expert Andrew D. Skibo as the Global Head of Biologics Operations
6/17/2021
Blue Water Vaccines, Inc., a biopharmaceutical company, announced that it has engaged the services of former Congressman Theodore Scott Yoho, as the Head of Business Development and veteran vaccine manufacturing specialist Andrew D. Skibo as Global Head of Biologics Operations.
-
Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients
6/17/2021
Elekta announced that its Elekta Harmony* radiation therapy system recently received U.S. FDA 510 clearance, paving the way for U.S. clinics to harness the system to treat a comprehensive range of indications using the latest radiotherapy techniques.
-
Foresight Diagnostics to Present a Vision of the New Standard of Lymphoma MRD Detection at the 16th International Conference on Malignant Lymphoma
6/17/2021
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced that clinical performance of its minimal residual disease detection platform in diffuse large B-cell lymphoma will be presented at the 16th International Conference on Malignant Lymphoma on June 18-22, 2021.
-
Aptinyx to Participate in Upcoming Investor Conferences - June 17, 2021
6/17/2021
Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, announced that the Company will be participating in two upcoming investor conferences
-
Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings
6/16/2021
Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels
-
PierianDx and Intermountain Healthcare Combine Expertise to Advance Myriad Genetics’ Tumor Test Offering
6/16/2021
PierianDx, the global leader in clinical genomics knowledge, today announced that it will work with existing partner, Intermountain Healthcare, to support Myriad Genetics’ comprehensive germline and somatic tumor testing service
-
Ault Global Holdings Announces Alzamend Neuro Pricing of Initial Public Offering
6/16/2021
Ault Global Holdings, Inc., a diversified holding company, announced that Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, priced its initial public offering of 2,500,000 shares of common stock at a price to the public of $5.00 per share for gross proceeds of $12.5 million from the offering.